Charles Schwab
OPTR

Charles Schwab’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Charles Schwab’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-124,643
Closed -$1.58M – 3117
2013
Q3 		$1.58M Buy
124,643
+6,020
+5% +$79.8K ﹤0.01% 1982
2013
Q2 		$1.72M Buy
+118,623
New +$1.73M ﹤0.01% 1849

Charles Schwab's OPTR Position: Q4 2013 in Review

Charles Schwab sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 124,643 shares — an estimated $1.58M sold.

Charles Schwab first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.72M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Charles Schwab reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Charles Schwab sold 124,643 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.58M.
  • Charles Schwab first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Charles Schwab's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.72M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Charles Schwab's 13F filing for Q4 2013, filed 14 Feb 2014.